Search details
1.
Cancer management during the COVID-19 world pandemic.
Cancer Immunol Immunother
; 72(11): 3427-3444, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37642709
2.
Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications.
Int J Mol Sci
; 24(11)2023 Jun 02.
Article
in English
| MEDLINE | ID: mdl-37298642
3.
A Case-Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection.
Int J Mol Sci
; 24(10)2023 May 10.
Article
in English
| MEDLINE | ID: mdl-37239866
4.
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.
Breast Cancer Res
; 24(1): 71, 2022 10 28.
Article
in English
| MEDLINE | ID: mdl-36307826
5.
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study.
Curr Issues Mol Biol
; 44(9): 4255-4267, 2022 Sep 15.
Article
in English
| MEDLINE | ID: mdl-36135204
6.
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.
Oncologist
; 27(7): e561-e570, 2022 07 05.
Article
in English
| MEDLINE | ID: mdl-35278078
7.
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
Lancet Oncol
; 22(12): 1669-1680, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34741822
8.
Direct comparison of three different mathematical models in two independent datasets of EUSOMA certified centers to predict recurrence and survival in estrogen receptor-positive breast cancer: impact on clinical practice.
Breast Cancer Res Treat
; 187(2): 455-465, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33646494
9.
p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis.
Molecules
; 26(20)2021 Oct 14.
Article
in English
| MEDLINE | ID: mdl-34684792
10.
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study.
Breast Cancer Res Treat
; 184(2): 421-431, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32770287
11.
The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments.
Int J Mol Sci
; 21(6)2020 Mar 16.
Article
in English
| MEDLINE | ID: mdl-32188012
12.
Mutant p53 as an Antigen in Cancer Immunotherapy.
Int J Mol Sci
; 21(11)2020 Jun 08.
Article
in English
| MEDLINE | ID: mdl-32521648
13.
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
Lancet Oncol
; 20(10): 1360-1369, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31494037
14.
The prognostic value of PI3K mutational status in breast cancer: A meta-analysis.
J Cell Biochem
; 119(6): 4287-4292, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29345357
15.
Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit.
Br J Cancer
; 119(12): 1487-1494, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30478407
16.
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer.
Invest New Drugs
; 36(6): 1133-1137, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30083960
17.
Familial aggregation of gastric cancer with microsatellite instability.
Acta Chir Belg
; 118(5): 287-293, 2018 Oct.
Article
in English
| MEDLINE | ID: mdl-30071769
18.
Lower urinary tract infections from external beam radiation therapy in prostate cancer: A single institution experience.
Rep Pract Oncol Radiother
; 23(4): 298-299, 2018.
Article
in English
| MEDLINE | ID: mdl-30100818
19.
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting.
Oncologist
; 22(6): 648-654, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28432226
20.
Risk of hypertension with ramucirumab-based therapy in solid tumors: data from a literature based meta-analysis.
Invest New Drugs
; 35(4): 518-523, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28285368